You are here

  • Home
  • Archive
  • Volume 78, Issue 1
  • Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1

Citation Tools

Article menu
Download PDFPDF
Letter
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mammen AL, Rajan A, Pak K, et al
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1
Annals of the Rheumatic Diseases 2019;78:150-152.